Axon Q1 2026 slides: AI revenue surges 700%, guidance raised

Axon posted Q1 2026 revenue of $807.35 million, up 34% year over year, with EPS of $1.61 beating consensus and revenue topping estimates by 3.71%. Management raised full-year 2026 revenue growth guidance to 30%-32% from 27%-30% while maintaining an adjusted EBITDA margin target of about 25.5%. AI-related revenue surged more than 700% and future contracted bookings rose 44% to $14.3 billion, though the stock remains down 34% over six months and trades at a 252 P/E.

Analysis

The cleanest read-through is not “AI is working,” but that Axon is turning software attach into a valuation multiple defense mechanism. When recurring revenue and bookings are compounding at that pace, the market eventually stops underwriting the company like a hardware vendor and starts valuing it like a mission-critical workflow platform; that transition is what can re-rate the stock over the next 6-18 months even if reported growth cools modestly. The second-order effect is competitive: any public-safety software rival now has to displace an installed base with entrenched data, training, and evidence workflows, which is far harder than selling a point product.

The near-term risk is that the stock still trades like a perfection story while the business is entering the law of large numbers. A premium multiple becomes fragile if growth merely normalizes from the low-30s to the mid-20s, especially if procurement cycles lengthen or there is any evidence of deal slippage in state/local budgets. That creates a gap where fundamentals can remain excellent but the share price underperforms for several quarters as investors wait for margin expansion to prove out.

The contrarian view is that the market may be underestimating how much of this is already in the price of future optionality, not current earnings. The upside case likely requires successful penetration in adjacent verticals and sustained AI monetization; if those stall, the installed base alone may not justify the current multiple. On the other hand, because the product is embedded in compliance and workflow, downside may be limited to multiple compression rather than a true growth break, making this more suitable for structured exposure than outright chasing.

Key Decisions for Investors

• Stay long AXON only via pullback entries: add on 8-12% post-earnings weakness or a market-wide risk-off tape, with a 6-12 month horizon; upside is re-rating if recurring mix and AI attach continue, but avoid paying peak multiple for momentum.
• Use a call spread instead of common stock for the next 3-6 months: buy AXON 6-9 month call spreads to express continued execution while capping valuation risk; this is the cleaner risk/reward if growth persists but the multiple stalls.
• Pair trade: long AXON / short a lower-quality public-safety or enterprise workflow software peer if available in book, to isolate execution and lock in relative multiple expansion rather than beta.
• If already long AXON, trim into strength above prior resistance and re-establish on confirmation of guide raise cadence next quarter; the stock can drift higher, but the asymmetry worsens as the multiple expands faster than the fundamentals.
• For event-driven traders, sell puts 1-2 quarters out at strikes 10-15% below spot to monetize elevated implied volatility while expressing willingness to own on valuation compression.